Many different studies have reported that Gal-3 concentrations are associated with incident HF and mortality in the general population and measurement of serum Gal-3 levels may be useful in predicting mortality for all-cause and cardiovascular disease (CVD) [101,102,103,331]. This evidence concerns the gene LGALS3 and cardiovascular disorder.